July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
What Makes the CISTO Study Unique? Patient Voices, PCORI Funding, and Long-Term Vision
Jun 4, 2025, 11:40

What Makes the CISTO Study Unique? Patient Voices, PCORI Funding, and Long-Term Vision

In this second part of OncoDaily Talks, Dr. Chandler Park speaks with Dr. John Gore, urologist at the University of Washington and Fred Hutchinson Cancer Center, about the ongoing impact of the CISTO study following its presentation at AUA 2025.

  • Dr. Gore reflects on the AUA Plenary presentation and the effort to publish their findings
  • He shares insights into the long-term follow-up plans with 2- and 5-year outcomes
  • The origins of the CISTO study are explored, including its patient-driven design through the Bladder Cancer
  • Advocacy Network (BCAN) and PCORI funding
  • Dr. Gore explains why the study was designed as an observational cohort rather than a randomized trial, based on direct patient feedback